This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université´ D'aix-Marseille, Aix-Marseille Université. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 5,383 
2 out of 237 
1 out of 13 
Years Active: 2016-2022
Title: The Innovations of Mikael Elias
Introduction
Mikael Elias is a notable inventor based in Florange, France. He has made significant contributions to the field of biochemistry, particularly in the development of mutated phosphotriesterase enzymes. With a total of 4 patents, his work focuses on enhancing enzyme stability and activity for various applications.
Latest Patents
Mikael Elias's latest patents include groundbreaking innovations. One of his patents involves mutated phosphotriesterase enzymes that exhibit improved stability and activity, specifically for degrading organophosphorus compounds. Another significant patent is for vulcanisaetal phosphotriesterase-like lactonases (PLL) that possess enhanced properties. This invention features a mutated hyperthermophilic PTE with lactonase activity derived from a hyperthermophilic phosphotriesterase. The mutated PTE includes at least one mutation chosen from 55 putative positions, resulting in enhanced properties. These innovations have potential applications as bioscavengers of organophosphate compounds or as quorum quenchers for bacteria that utilize lactones for communication.
Career Highlights
Throughout his career, Mikael Elias has worked with prestigious institutions. He has been associated with the Centre National de la Recherche Scientifique and the Université d'Aix-Marseille. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Mikael has collaborated with notable colleagues, including Eric Chabriere and Julien Hiblot. Their combined expertise has furthered the development of innovative solutions in the field of biochemistry.
Conclusion
Mikael Elias is a distinguished inventor whose work in enzyme technology has led to significant advancements in the degradation of harmful compounds. His contributions continue to impact the scientific community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile